The new inactivated oral vaccine Euvichol-S for cholera has received prequalification by the World Health Organisation (WHO).
There were 473,000 cholera cases reported to WHO in 2022, double the number from 2021.
Further increase of cases by 700,000 was estimated for 2023.
Currently, 23 countries are reporting cholera outbreaks with most severe impacts seen in the Comoros, Democratic Republic of the Congo, Ethiopia, Mozambique, Somalia, Zambia and Zimbabwe.